Lyme literate care, explained

If you’ve been searching for help with chronic Lyme disease symptoms, you’ve probably already encountered the term “Lyme literate.” You may also have encountered the divide it represents. One set of doctors follows IDSA guidelines and treats Lyme as a short-course antibiotic problem. Another set treats ongoing symptoms as evidence of unresolved infection or post-infection inflammation requiring different protocols.

The divide is real and it’s been going on for over two decades. Patients land in the middle of it, often after years of being told their symptoms are anxiety, fibromyalgia, chronic fatigue syndrome, or “all in your head.” If you’re trying to figure out who to trust and what to do, here’s the honest version.

The two-camp picture

Camp one: IDSA guidelines. The Infectious Diseases Society of America publishes treatment guidelines for Lyme that are widely adopted by conventional infectious disease specialists, primary care physicians, and most hospital systems. Their position, simplified: Lyme disease is treatable with 2 to 4 weeks of doxycycline or comparable antibiotic. Symptoms that persist after treatment are not ongoing infection. They’re called “post-treatment Lyme disease syndrome” (PTLDS) and are managed symptomatically. Long-course antibiotics are not recommended.

Camp two: ILADS guidelines. The International Lyme and Associated Diseases Society publishes alternative guidelines based on a different reading of the clinical evidence and decades of practice with chronically symptomatic patients. Their position, simplified: standard short-course antibiotics fail in a meaningful percentage of patients, particularly those with delayed diagnosis or multiple coinfections. Ongoing symptoms in many patients reflect persistent infection or biofilm-protected pathogens that require longer, layered, individualized treatment.

Both camps include credentialed clinicians who are convinced they’re right. Both can cite studies. The patients caught in the middle are usually the ones who got sick, did everything the IDSA-aligned doctor told them to do, and didn’t get better.

Lyme literate care is shorthand for the ILADS-aligned approach. Practitioners who use the term are typically trained through ILADS or worked with ILADS-trained mentors, and they treat patients with persistent Lyme-related symptoms using protocols that conventional medicine doesn’t offer.

Why the divide exists in the first place

Three reasons, briefly:

1. Lyme testing is imperfect. Standard two-tier testing (ELISA followed by Western blot) was designed for surveillance, not diagnosis. It misses a meaningful percentage of true cases. Estimates range from 20% to 50% depending on the study and the patient population. That means many patients with Lyme test negative. IDSA guidelines say “negative test, not Lyme.” ILADS-aligned providers say “negative test, but the clinical picture says we should treat anyway in many cases.”

2. Lyme bacteria are unusually adaptive. Borrelia burgdorferi (and related species) can shift forms (spirochete to round body to biofilm-protected colonies) under stress, including antibiotic stress. Some forms are resistant to certain antibiotics. Some can persist in tissues that standard antibiotics don’t penetrate well. Whether this means “live infection persists in chronic Lyme cases” or “all chronic symptoms are post-infection inflammation, not active infection” is exactly what the two camps disagree about.

3. Coinfections complicate everything. Ticks rarely transmit Lyme alone. Babesia, Bartonella, Mycoplasma, Ehrlichia, Anaplasma, and viral coinfections frequently come along for the ride. Standard Lyme testing doesn’t catch any of them. Standard Lyme treatment doesn’t address any of them. Patients treated for “Lyme” who actually have Lyme + Babesia + Bartonella don’t fully recover, and conventional medicine often has no framework to explain why.

What ILADS-trained providers actually do differently

The mechanics, simplified:

Diagnosis is clinical first, lab-supported second. A Lyme literate provider takes a thorough history (tick exposure, symptom timeline, response to prior treatments, family history), does a comprehensive symptom inventory, and uses lab testing to support clinical judgment, not replace it. Standard ELISA + Western blot are ordered, but more sensitive testing (Vibrant America’s Tick-Borne Diseases panel, IGeneX immunoblot, T-Lab when available) is added when warranted. We assume some patients will be clinically Lyme-positive and lab-negative.

Coinfections are tested for and treated. A Lyme literate workup typically includes testing for Babesia, Bartonella, Mycoplasma, Ehrlichia, viral reactivations (EBV, HHV-6, CMV), and increasingly mold/CIRS markers (which often overlap clinically with Lyme). When found, each pathogen is addressed with appropriate protocols.

Treatment is layered and phased. Rather than a single 2 to 4 week antibiotic course, treatment typically runs in phases over months. Phase one is preparation: drainage, immune support, mast cell stabilization where needed. Phase two is targeted antimicrobial treatment: pharmaceutical antibiotics, herbal antimicrobials like Cryptolepis or Japanese knotweed, homeopathic/spagyric protocols like Des Bio nosodes. Phase three is consolidation and immune restoration. Phase four is maintenance.

Treatment intensity is calibrated to patient tolerance. Herxheimer reactions (die-off) are managed by pacing dosing, supporting drainage, and adjusting protocols. Aggressive treatment in a patient who can’t tolerate it is counterproductive.

Patients are seen as collaborators in long-term work. Lyme treatment is rarely a “take this for a month and be cured” affair. It’s usually 6 to 18 months minimum, often longer for complex layered cases. Patients who do well are the ones who become informed partners in their own protocol.

Who’s a candidate for Lyme literate care

Several patient profiles repeatedly land in our practice:

• Confirmed Lyme, treated, symptoms persisted or returned. ELISA + Western blot were positive, doxycycline was prescribed, you completed the course, but symptoms either never fully resolved or returned weeks to months later. Conventional medicine says “post-treatment Lyme syndrome, manage symptoms.” We test for ongoing infection markers and often find treatable patterns.
• Suspected Lyme, never confirmed by standard testing. Tick exposure or EM rash or classic symptom pattern. ELISA was negative or inconclusive. You were told it’s “not Lyme” without further investigation. We use more sensitive testing and clinical assessment.
• Years of “mystery illness” with no diagnosis. Fatigue, brain fog, joint pain, neurological symptoms, autonomic issues, gut problems, sleep dysfunction. Multiple specialists, multiple normal labs, no clear answer. Lyme + coinfections is a common hidden driver in this presentation. Mold/CIRS is another.
• Long COVID with infectious overlap. COVID infection that uncovered or reactivated something else. Long COVID and chronic Lyme have substantial symptom overlap. Many long COVID cases have an underlying infectious component (Lyme, EBV, mast cell activation) that conventional long-haul protocols don’t address.
• Children of mothers with Lyme. Congenital transmission of Borrelia is documented. Children with unexplained chronic illness whose mothers have a Lyme history warrant evaluation.

Who’s NOT a candidate

We try to be honest in initial consultations. Some patients aren’t well-served by Lyme literate care, including:

• Patients looking for a single quick-fix diagnosis. Lyme treatment is long, complex, and not always conclusive. If you’re looking for a rapid resolution, you’ll be disappointed.
• Patients unwilling to do specialty lab testing. Without testing we’re guessing. Specialty labs (Vibrant, IGeneX, mycotoxin panels) cost money and are not insurance-covered.
• Patients who can’t afford treatment-phase budgets. During active treatment, monthly out-of-pocket budgets typically run $300 to $800 including medications, supplements, and some lab work. We don’t want to start protocols a patient can’t sustain.
• Patients who actually have a different primary diagnosis. Some patients carry Lyme labels for years when the actual driver is mold, hormonal, autoimmune, or psychiatric. We screen for this and refer appropriately.

What to ask a Lyme literate practice

If you’re evaluating any clinic that claims to do Lyme literate care, here are useful questions:

1. Are your providers ILADS-trained or have they completed the ILADS preceptorship or fellowship? This is the most-recognized credential in the space.
2. What testing do you order, beyond standard ELISA + Western blot? A real Lyme literate practice uses sensitive testing.
3. Do you also test and treat for coinfections (Babesia, Bartonella, Mycoplasma, viral reactivation)? If they say “we just treat Lyme,” that’s a red flag.
4. What does a typical treatment timeline look like? Honest answer: usually 6 to 18 months. Anyone promising faster doesn’t understand the disease.
5. What’s your approach to Herxheimer reactions? A real practice has a documented protocol. They expect die-off and manage it.
6. What modalities do you use? Pharmaceutical antibiotics, herbal antimicrobials, homeopathic/spagyric remedies (Des Bio), IV therapy where available, supportive care. A practice that uses only one approach is incomplete.
7. What do treatment-phase costs look like? Get this in writing before you start.
8. What happens if I don’t respond? Real practices adjust protocols, retest, and consider alternative diagnoses. They don’t just keep prescribing the same thing.

Where Align fits in

We’re a small, telehealth-first practice in Utah. Our Lyme literate work uses telehealth-deliverable protocols: comprehensive history-taking and lab review, homeopathic and spagyric protocols, herbal antimicrobials, pharmaceutical antimicrobials when indicated, binder protocols, drainage and immune support, and ongoing protocol management.

In-person modalities (SOT injections, IV therapy) will be available when our physical clinic opens in Q3 2026. For patients whose protocol benefits from those modalities now, we discuss timing and refer where appropriate.

We’re honest about what we can and can’t do. We won’t take you on if we’re not the right team. We won’t promise outcomes we can’t deliver. And we won’t pretend Lyme treatment is fast or simple, because it usually isn’t.

A note on the IDSA / ILADS conflict

You’ll find articles online from both sides arguing the other side is wrong, dangerous, unscientific, etc. Some of those articles are fair criticism. Some are political. Most patients don’t have time to evaluate the underlying evidence themselves.

Here’s what we’d suggest instead. If you’ve been told by IDSA-aligned doctors that there’s nothing wrong with you, but you’re still sick, an ILADS-aligned evaluation is worth pursuing. The worst case is you spend a Comprehensive Functional Medicine Intake ($450, 60 minutes) finding out we’re not the right team. The best case is you finally get a workup and a protocol that helps.

If you want to talk about whether Lyme literate care makes sense for your situation, our consultation is free. If we’re not the right team for any reason, we’ll tell you and try to point you somewhere we think might be.